Dan Shochat

Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia

Philip R. Hamann, Lois M. Hinman, Irwin Hollander et al. · Bioconjugate Chemistry · 2001 · 582 citations

Gemtuzumab Ozogamicin, Immunology, Pharmacotherapy +16

<i>N</i>-Succinyl-(β-alanyl-<scp>l</scp>-leucyl-<scp>l</scp>-alanyl-<scp>l</scp>-leucyl)doxorubicin:  An Extracellularly Tumor-Activated Prodrug Devoid of Intravenous Acute Toxicity

Anne-Marie Fernandez, Kim Van derpoorten, Luc Dasnois et al. · Journal of Medicinal Chemistry · 2001 · 76 citations

Pharmaceutical Science, Intravenous Administration, Immunology +19

Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies.

André Trouet, A. Passioukov, Kim Van derpoorten et al. · PubMed · 2001 · 68 citations

Good Blood Stability, Immunology, Tumor Biology +16

Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancer.

Ruby F. Meredith, M.B. Khazaeli, Tiepu Liu et al. · PubMed · 1992 · 66 citations

Immunology, Pathology, Dose Fractionation +17

Protease digestion of colonic mucin. Evidence for the existence of two immunochemically distinct mucins.

David V. Gold, Dan Shochat, Frederick W. Miller · Journal of Biological Chemistry · 1981 · 58 citations · Full text